{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:49:43Z","timestamp":1783691383277,"version":"3.55.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1111\/bjd.16679","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T06:16:59Z","timestamp":1523945819000},"page":"1141-1147","source":"Crossref","is-referenced-by-count":77,"title":["Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation"],"prefix":"10.1093","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-9151","authenticated-orcid":false,"given":"K.","family":"Kridin","sequence":"first","affiliation":[{"name":"Department of Dermatology; Rambam Health Care Campus; Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"key":"10.1111\/bjd.16679-BIB0001|bjd16679-cit-0001","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI113803","article-title":"Isolation of complementary DNA for bullous pemphigoid antigen by use of patients\u2019 autoantibodies","volume":"82","author":"Stanley","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.16679-BIB0002|bjd16679-cit-0002","doi-asserted-by":"crossref","first-page":"17784","DOI":"10.1016\/S0021-9258(18)55195-4","article-title":"Human bullous pemphigoid antigen (BPAG1): amino acid sequences deduced from cloned cDNAs predict biologically important peptide segments and protein domains","volume":"266","author":"Sawamura","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/bjd.16679-BIB0003|bjd16679-cit-0003","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.16679-BIB0004|bjd16679-cit-0004","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0065-2776(08)60503-9","article-title":"Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion","volume":"53","author":"Stanley","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1111\/bjd.16679-BIB0005|bjd16679-cit-0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","article-title":"Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16679-BIB0006|bjd16679-cit-0006","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Bl\u00f6cker","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16679-BIB0007|bjd16679-cit-0007","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2133.2012.11108.x","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort","volume":"167","author":"Della Torre","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16679-BIB0008|bjd16679-cit-0008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.iac.2012.04.002","article-title":"Clinical features and practical diagnosis of bullous pemphigoid","volume":"32","author":"Schmidt","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1111\/bjd.16679-BIB0009|bjd16679-cit-0009","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1067\/mjd.2002.120445","article-title":"Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoid","volume":"47","author":"Schmidt","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16679-BIB0010|bjd16679-cit-0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-4632.2004.02457.x","article-title":"Prodromal bullous pemphigoid","volume":"45","author":"Lamb","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.16679-BIB0011|bjd16679-cit-0011","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0190-9622(93)70179-W","article-title":"Nonbullous pemphigoid: prodrome of bullous pemphigoid or a distinct pemphigoid variant?","volume":"29","author":"Strohal","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16679-BIB0012|bjd16679-cit-0012","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/archderm.1979.04010030028010","article-title":"Localized pemphigoid simulating dyshidrosiform dermatitis","volume":"115","author":"Levine","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16679-BIB0013|bjd16679-cit-0013","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/cyto.2000.0791","article-title":"Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils. A preliminary observation","volume":"13","author":"Engineer","year":"2001","journal-title":"Cytokine"},{"key":"10.1111\/bjd.16679-BIB0014|bjd16679-cit-0014","first-page":"897","article-title":"Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins","volume":"148","author":"Borrego","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.16679-BIB0015|bjd16679-cit-0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12016-007-0030-y","article-title":"The pathophysiology of bullous pemphigoid","volume":"33","author":"Kasperkiewicz","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1111\/bjd.16679-BIB0016|bjd16679-cit-0016","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1346-8138.1992.tb03247.x","article-title":"Ultrastructural aspects of infiltrated eosinophils in bullous pemphigoid","volume":"19","author":"Iryo","year":"1992","journal-title":"J Dermatol"},{"key":"10.1111\/bjd.16679-BIB0017|bjd16679-cit-0017","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/1523-1747.ep12505711","article-title":"Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient","volume":"78","author":"Dvorak","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16679-BIB0018|bjd16679-cit-0018","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0190-9622(93)70170-X","article-title":"Granulocyte activation in bullous diseases: release of granular proteins in bullous pemphigoid and pemphigus vulgaris","volume":"29","author":"Czech","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16679-BIB0019|bjd16679-cit-0019","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0738-081X(87)90057-5","article-title":"The molecular pathogenesis of bullous pemphigoid","volume":"5","author":"Wintroub","year":"1987","journal-title":"Clin Dermatol"},{"key":"10.1111\/bjd.16679-BIB0020|bjd16679-cit-0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.1980.tb01683.x","article-title":"Cellular events leading to blister formation in bullous pemphigoid","volume":"103","author":"Dubertret","year":"1980","journal-title":"Br J Dermatol"},{"issue":"1 Suppl. 40","key":"10.1111\/bjd.16679-BIB0021|bjd16679-cit-0021","first-page":"S20","article-title":"New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria","volume":"24","author":"Blank","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/bjd.16679-BIB0022|bjd16679-cit-0022","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/BF01105794","article-title":"High affinity IgE receptor (Fc epsilon RI) expression on eosinophils infiltrating the lesions and mite patch tested sites in atopic dermatitis","volume":"287","author":"Tanaka","year":"1995","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.16679-BIB0023|bjd16679-cit-0023","doi-asserted-by":"crossref","first-page":"e107725","DOI":"10.1371\/journal.pone.0107725","article-title":"Human eosinophils express the high affinity IgE receptor, Fc\u03b5RI, in bullous pemphigoid","volume":"9","author":"Messingham","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.16679-BIB0024|bjd16679-cit-0024","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/CDLI.2.3.297-301.1995","article-title":"Connective tissue mast cells exhibit time-dependent degranulation heterogeneity","volume":"2","author":"Kaminer","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1111\/bjd.16679-BIB0025|bjd16679-cit-0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/1744666X.2016.1123092","article-title":"IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases","volume":"12","author":"Beek","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1111\/bjd.16679-BIB0026|bjd16679-cit-0026","first-page":"249","article-title":"Activation of Fc epsilon RI-positive eosinophils in bullous pemphigoid","volume":"7","author":"Kasahara-Imamura","year":"2001","journal-title":"Int J Mol Med"},{"key":"10.1111\/bjd.16679-BIB0027|bjd16679-cit-0027","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0190-9622(83)70073-3","article-title":"Bullous pemphigoid: a cause of peripheral blood eosinophilia","volume":"8","author":"Bushkell","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16679-BIB0028|bjd16679-cit-0028","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0190-9622(87)80227-X","article-title":"Blood eosinophilia as a severity marker for bullous pemphigoid","volume":"16","author":"Bernard","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16679-BIB0029|bjd16679-cit-0029","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16679-BIB0030|bjd16679-cit-0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.1994.tb02909.x","article-title":"Bullous pemphigoid in a 19-year-old woman. A case with unusual target antigens","volume":"130","author":"Mori","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16679-BIB0031|bjd16679-cit-0031","first-page":"69","article-title":"Serum levels of IgE antibodies to the immunodominant BP180-NC16A domain correlate with the disease activity of patients with bullous pemphigoid","volume":"13","author":"Van Beek","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/bjd.16679-BIB0032|bjd16679-cit-0032","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","article-title":"Omalizumab therapy for bullous pemphigoid","volume":"71","author":"Yu","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16679-BIB0033|bjd16679-cit-0033","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","article-title":"Eosinophils: biological properties and role in health and disease","volume":"38","author":"Hogan","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/bjd.16679-BIB0034|bjd16679-cit-0034","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.134.9.1075","article-title":"Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group","volume":"134","author":"Vaillant","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16679-BIB0035|bjd16679-cit-0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.0022-202X.2004.22603.x","article-title":"BP230- and BP180-specific auto-antibodies in bullous pemphigoid","volume":"122","author":"Thoma-Uszynski","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16679-BIB0036|bjd16679-cit-0036","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16679-BIB0037|bjd16679-cit-0037","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0025-6196(11)62962-5","article-title":"Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment","volume":"80","author":"Tefferi","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/bjd.16679-BIB0038|bjd16679-cit-0038","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaci.2010.04.011","article-title":"Practical approach to the patient with hypereosinophilia","volume":"126","author":"Roufosse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.16679-BIB0039|bjd16679-cit-0039","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2008.07.022","article-title":"Mortality of bullous pemphigoid: An evaluation of 223 patients and comparison with the mortality in the general population in the United States","volume":"59","author":"Parker","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16679-BIB0040|bjd16679-cit-0040","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaad.2014.05.006","article-title":"Mortality of patients with bullous pemphigoid in Korea","volume":"71","author":"Lee","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16679-BIB0041|bjd16679-cit-0041","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16679","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16679\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:41:10Z","timestamp":1676382070000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/179\/5\/1141\/6732603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16679","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,4]]}}}